Provenienza dei contatti di primo grado di Mark Smith
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Angarus Therapeutics, Inc.
 Angarus Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Angarus Therapeutics, Inc. engages in the development of immuno-oncology therapies. It specializes in modulating the tumor microenvironment by activating innate immunity. The company was founded by Ling Yin Li, Chih Ping Liu, and Mark Smith and is headquartered in Sunnyvale, CA.
3
| Holding Company | Hospital/Nursing Management | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Mark Smith tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ROSSMAX INTERNATIONAL LTD. | Medical Distributors | Chief Executive Officer | |
Rossmax (Shanghai) Incorporation Ltd.
 Rossmax (Shanghai) Incorporation Ltd. Medical SpecialtiesHealth Technology Part of Rossmax International Ltd., Rossmax (Shanghai) Incorporation Ltd. is a Chinese company that manufactures and distributes electrometrical devices. The company is based in Shanghai, China. | Medical Specialties | Director/Board Member | |
| Rossmax Innotek Corp. | Director/Board Member | ||
| WE CAN MEDICINES CO., LTD. | Drugstore Chains | Director/Board Member | |
| Rossmax Pharmaceutical Corp. | Director/Board Member | ||
Atlantean Corp.
 Atlantean Corp. Engineering & ConstructionIndustrial Services Atlantean Corp. engages in the engineering and product development of health care products. The frim offers plus oximeter and triggered nebulizer bottle set. The company was founded in 2008 and is headquartered in Hsinchu, Taiwan. | Engineering & Construction | Director/Board Member | |
| RMJ Corp. Ltd. | Director/Board Member | ||
| Ho Sang Medical Technology Co., Ltd. | Director/Board Member | ||
| Cardiocare Co., Ltd. | Director/Board Member | ||
| National Chengchi University | College/University | Undergraduate Degree | |
Tranquis Therapeutics, Inc.
 Tranquis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tranquis Therapeutics, Inc. discovers and develops novel immuno-therapeutics for neurological diseases. It offers treatment for central nervous system (CNS) disorders, including Amyotrophic Lateral Sclerosis, Parkinson 's disease, Alzheimer?s Disease, and age-related neuropathology. The company was founded by Chih-Ping Liu and Khoa D. Nguyen in June 2016 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Founder | |
| Stanford University | College/University | Undergraduate Degree | |
| University of California, Los Angeles | College/University | Masters Business Admin | |
| DURECT CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Taiwan | 9 |
| Stati Uniti | 6 |
| Cina | 2 |
| Giappone | 2 |
Settori
| Health Technology | 5 |
| Consumer Services | 4 |
| Distribution Services | 2 |
| Retail Trade | 2 |
| Industrial Services | 2 |
Posizioni
| Director/Board Member | 9 |
| Chief Executive Officer | 3 |
| Chairman | 3 |
| Founder | 3 |
| Corporate Officer/Principal | 3 |
Contatti più connessi
| Insiders | |
|---|---|
| Chih Ping Liu | 12 |
| Nigel Ray | 5 |
| Ling Yin Li | 1 |
- Borsa valori
- Insiders
- Mark Smith
- Connessioni Società
